Evidence map›Paper›PMID 41735999›Full record

ArticleBMC oral health2026

Evaluation of contact-active antibacterial properties of cetylpyridinium chloride-graphene oxide coatings on dental restorative and titanium surfaces: an in vitro study.

Keisuke Okubo, Gen Kano, Masato Komoda, Hideyuki Kamata, Shin Nakamura, Yuki Shinoda-Ito, Kazuhiro Omori, Yuta Nishina, Shogo Takashiba

Abstract read
In one paragraph

Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Keisuke Okubo *Department of Periodontics and Endodontics, Field of Medical Development, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8525, Japan. okubok@okayama-u.ac.jp.
Gen Kano *Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, Okayama, 700-8525, Japan.
Masato KomodaResearch Institute for Interdisciplinary Science, Okayama University, Tsushima-naka, Kita-ku, Okayama, 700-8530, Japan.
Hideyuki KamataGraduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, Okayama, 700-8525, Japan.
Shin NakamuraDepartment of Pathophysiology - Periodontal Science, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8525, Japan.
Yuki Shinoda-ItoDepartment of Pathophysiology - Periodontal Science, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8525, Japan.
Kazuhiro OmoriDepartment of Pathophysiology - Periodontal Science, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8525, Japan.
Yuta NishinaResearch Institute for Interdisciplinary Science, Okayama University, Tsushima-naka, Kita-ku, Okayama, 700-8530, Japan.
Shogo TakashibaDepartment of Pathophysiology - Periodontal Science, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8525, Japan.

Funding

JSPS KAKENHI 23K19691JST CREST JPMJCR24S6
6 · The paper itself

Abstract

objectiveBiofilm formation on dental restorative materials and implant surfaces plays a central role in the development of dental caries, periodontal disease, and peri-implantitis. Durable antimicrobial surface treatments that inhibit bacterial adhesion and biofilm formation remain a significant unmet need in restorative and implant dentistry. Therefore, this study aimed to develop a composite coating combining cetylpyridinium chloride and graphene oxide, and to evaluate its durable antibacterial surface modification under in vitro conditions.

methodsA composite coating consisting of cetylpyridinium chloride and graphene oxide was prepared and applied to composite resin and titanium surfaces. Antibacterial activity against Streptococcus mutans and Porphyromonas gingivalis was evaluated using adenosine triphosphate assays and fluorescence-based live/dead staining. Coating retention after washing and air-drying was assessed by optical microscopy and Raman spectroscopy.

resultsCetylpyridinium chloride-graphene oxide-coated surfaces showed a significant reduction in bacterial viability compared with phosphate-buffered saline, ethanol, and cetylpyridinium chloride-only controls. Antibacterial effects were maintained after rinsing and air-drying on both composite resin and titanium surfaces. Raman spectroscopy confirmed the persistence of characteristic graphene oxide bands after washing, indicating stable retention of the coating on the material surfaces.

conclusionsCetylpyridinium chloride–graphene oxide coatings demonstrate sustained surface-associated antibacterial activity against key cariogenic and periodontal pathogens and remain stably adhered to common dental restorative and implant materials after washing. These findings suggest that cetylpyridinium chloride–graphene oxide coatings may serve as a durable contact-active surface modification strategy to reduce biofilm formation associated with dental caries and peri-implantitis.

Indexed as

Anti-Bacterial AgentsCetylpyridiniumCoated Materials, BiocompatibleComposite ResinsGraphiteTitaniumBiofilmsIn Vitro TechniquesMaterials TestingPorphyromonas gingivalisSpectrum Analysis, RamanStreptococcus mutansSurface PropertiesAnti-Bacterial AgentsCetylpyridiniumCoated Materials, BiocompatibleComposite Resinsgraphene oxideGraphiteTitaniumCetylpyridinium chlorideGraphene oxideOral pathogenic bacteriaWash-resistant antibacterial coating

Identifiers

PMID41735999
PMCPMC13037235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.